Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis

Oncotype DX is a commercial assay frequently used for making chemotherapy decisions in estrogen receptor (ER)-positive breast cancers. The result is reported as a recurrence score ranging from 0 to 100, divided into low-risk (<18), intermediate-risk (18–30), and high-risk (≥31) categories. Our pi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Klein, Molly E, Dabbs, David J, Shuai, Yongli, Brufsky, Adam M, Jankowitz, Rachel, Puhalla, Shannon L, Bhargava, Rohit
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3647116/
https://ncbi.nlm.nih.gov/pubmed/23503643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2013.36
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados